# Bonds Between Circulating Tumoral ADN (ctDNA) and the Development of Peritoneal Carcinomatosis for Patients Under PIPAC

> **NCT04766502** · NA · COMPLETED · sponsor: **Institut de Cancérologie de Lorraine** · enrollment: 20 (actual)

## Conditions studied

- Peritoneal Carcinomatosis

## Interventions

- **OTHER:** Blood sample (20 ml) and EORTC QLQC30 survey

## Key facts

- **NCT ID:** NCT04766502
- **Lead sponsor:** Institut de Cancérologie de Lorraine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-11
- **Primary completion:** 2024-12-10
- **Final completion:** 2025-01-07
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2025-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04766502

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04766502, "Bonds Between Circulating Tumoral ADN (ctDNA) and the Development of Peritoneal Carcinomatosis for Patients Under PIPAC". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04766502. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*